Search Results - "VanderWalde, A."

Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy by VanderWalde, Noam A., MD, Deal, Allison M., MS, Comitz, Elizabeth, MA, Stravers, Lori, MPH, CHES, Muss, Hyman, MD, Reeve, Bryce B., PhD, Basch, Ethan, MD, MSc, Tepper, Joel, MD, Chera, Bhishamjit, MD

“…Purpose To evaluate the association between functional status based on a geriatric assessment (GA) and outcomes of tolerance to treatment in patients with…”
Get full text

The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment by Maggiore, Ronald, MD, Zumsteg, Zachary S., MD, BrintzenhofeSzoc, Karlynn, PhD, MSW, Trevino, Kelly M., PhD, Gajra, Ajeet, MD, Korc-Grodzicki, Beatriz, MD, PhD, Epstein, Joel B., DMD, MSD, Bond, Stewart M., PhD, RN, AOCN, Parker, Ira, DDS, MA, MPH, Kish, Julie A., MD, Murphy, Barbara A., MD, VanderWalde, Noam A., MD

“…Older adults with head and neck squamous cell carcinoma (HNSCC) pose unique treatment and supportive care challenges to oncologists and other cancer care…”
Get full text

PD-L1 expression is strongly associated with TIGIT, FOXP3 and LAG3 across advanced cancers, but not OX40, TIM3 and IDO by Pal, S.K., Vanderwalde, A.M., Szeto, C., Reddy, S., Hamid, O.

Get full text

Differential expression of PD-L1 and immune biomarkers by age: Decreased expression in pediatric/AYA patients with advanced cancer by Hamid, O., Vanderwalde, A.M., Szeto, C., Reddy, S., Pal, S.K.

Get full text

Effectiveness of Chemoradiation for Head and Neck Cancer in an Older Patient Population by VanderWalde, Noam A., MD, Meyer, Anne Marie, PhD, Deal, Allison M., MS, Layton, J. Bradley, PhD, Liu, Huan, MA, Carpenter, William R., PhD, Weissler, Mark C., MD, Hayes, David N., MD, Fleming, Mary E., ANP, Chera, Bhishamjit S., MD

“…Purpose The purpose of this study was to compare chemoradiation therapy (CRT) with radiation therapy (RT) only in an older patient population with head and…”
Get full text

ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer by Voronkova, M. A., Johnson, B., Gandhi, N., Koomen, J. M., Patrick, M, Shanthi Bhupathi, S., Wu, V. M., Elliott, A., Vanderwalde, A., Halmos, B., Hazlehurst, L. A.

“…We have identified endoplasmic reticulum oxidoreductase 1 alpha ( ERO1A ) as a poor prognostic indicator in epidermal growth factor receptor (EGFR)-mutated…”
Get full text

Developing an electronic geriatric assessment to improve care of older adults with cancer receiving radiotherapy by VanderWalde, Noam A., Williams, Grant R.

“…Older adults make up a substantial proportion of patients diagnosed with cancer. Gaps in evidence of care for older adults with cancer leads to treatment…”
Get full text

The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma: does more really matter? by Drake, Justin A., Stiles, Zachary E., Behrman, Stephen W., Glazer, Evan S., Deneve, Jeremiah L., Somer, Bradley G., Vanderwalde, Noam A., Dickson, Paxton V.

“…Although neoadjuvant therapy is increasingly administered to patients with pancreatic ductal adenocarcinoma (PDAC), the impact of additional adjuvant therapy…”
Get full text

215 Using ALK IHC test to identify potential responders to ALK inhibitors outside of NSCLC by Xiu, J, Gatalica, Z, Abbott, B, Reddy, S, Vanderwalde, A, Braiteh, F

Get full text

Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies by VanderWalde, A M, Sun, C-L, Laddaran, L, Francisco, L, Armenian, S, Berano-Teh, J, Wong, F L, Popplewell, L, Somlo, G, Stein, A S, Nademanee, A, Krishnan, A, Kogut, N, Forman, S J, Bhatia, S

“…The probability of survival is conventionally calculated from autologous hematopoietic cell transplantation (aHCT). Conditional survival takes into account the…”
Get full text

24LBA Safety data from the phase 1b part of the MASTERKEY-265 study combining talimogene laherparepvec (T-VEC) and pembrolizumab for unresectable stage IIIB-IV melanoma by Long, G.V, Dummer, R, Ribas, A, Puzanov, I, Michielin, O, Vanderwalde, A, Andtbacka, R.H.I, Cebon, J, Fernandez, E, Malvehy, J, Olszanski, A.J, Gajewski, T.F, Kirkwood, J.M, Gause, C, Chen, L, Kaufman, D.R, Chou, J, Hodi, F.S

Get full text

Not just a number, the benefit of mixed methods studies: An editorial by VanderWalde, Noam A.

Get full text

Radiation Therapy in Older Adults With Cancer: A Critical Modality in Geriatric Oncology by Amini, Arya, Morris, Lucinda, Ludmir, Ethan B, Movsas, Benjamin, Jagsi, Reshma, VanderWalde, Noam A

“…Radiation therapy (RT) is a commonly used modality in the treatment of older adults with cancer, and RT represents an attractive oncologic treatment option,…”
Get full text

Treatment of Older Patients With Head and Neck Cancer: A Review by VanderWalde, Noam A., Fleming, Mary, Weiss, Jared, Chera, Bhishamjit S.

“…Learning Objectives Compare survival and toxicity outcomes of older patients with head and neck cancer with those of their younger cohorts. Describe the role…”
Get full text

Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial by Fine, Richard E., Gilmore, Richard C., Dietz, Jill R., Boolbol, Susan K., Berry, Michael P., Han, Linda K., Kenler, Andrew S., Sabel, Michael, Tomkovich, Kenneth R., VanderWalde, Noam A., Chen, Margaret, Columbus, Karen S., Curcio, Lisa D., Feldman, Sheldon M., Gold, Linsey, Hernandez, Lydia, Manahan, Eric R., Seedman, Susan A., Vaidya, Rashmi P., Sevrukov, Alexander B., Aoun, Hussein D., Hicks, Randy D., Simmons, Rache M.

“…Background The ICE3 trial is designed to evaluate the safety and efficacy of breast cryoablation, enabling women older than 60 years with low-risk early-stage…”
Get full text

Prevalence and impact of frailty and geriatric assessment-identified impairments among older adults diagnosed with head and neck cancers by Siwakoti, Krishmita, Giri, Smith, Nabell, Lisle, VanderWalde, Noam A., McDonald, Andrew, Williams, Grant R.

Get full text

Real-world treatment patterns among patients with unresected stage III non-small-cell lung cancer by Ryan, Kellie J, Skinner, Karen E, Fernandes, Ancilla W, Punekar, Rajeshwari S, Pavilack, Melissa, Walker, Mark S, VanderWalde, Noam A

“…Little is known about recent treatment patterns among patients with unresected stage III NSCLC in the real world. This retrospective study used medical records…”
Get full text

Predicting future cancer incidence by age, race, ethnicity, and sex by Garner, Wesley B., Smith, Benjamin D., Ludmir, Ethan B., Wakefield, Daniel V., Shabason, Jacob, Williams, Grant R., Martin, Michelle Y., Wang, Yuefeng, Ballo, Matthew T., VanderWalde, Noam A.

“…Cancer remains a substantial burden on society. Our objective was to update projections on the number of new cancer diagnoses in the United States by age,…”
Get full text

Real-world outcomes in patients with unresected stage III non-small cell lung cancer by Ryan, Kellie J., Skinner, Karen E., Fernandes, Ancilla W., Punekar, Rajeshwari S., Pavilack, Melissa, Walker, Mark S., VanderWalde, Noam A.

“…This study examined real-world clinical outcomes such as progression-free survival (PFS), time to metastasis (TTM), overall survival (OS), and health-related…”
Get full text

Sex-Based Disparities Among Cancer Clinical Trial Participants by Ludmir, Ethan B, Fuller, C David, Moningi, Shalini, Mainwaring, Walker, Lin, Timothy A, Miller, Austin B, Jethanandani, Amit, Espinoza, Andres F, Verma, Vivek, Smith, Benjamin D, Smith, Grace L, VanderWalde, Noam A, Holliday, Emma B, Guadagnolo, B Ashleigh, Stinchcombe, Thomas E, Jagsi, Reshma, Gomez, Daniel R, Minsky, Bruce D, Rödel, Claus, Fokas, Emmanouil

“…Abstract Landmark investigation two decades ago demonstrated sex-based disparities among participants in cancer cooperative group trials. Although federal…”
Get full text